182 related articles for article (PubMed ID: 2907957)
1. [Effects of bifemelane on central dopaminergic and cholinergic systems in rats].
Ushijima I; Tsutsumi C; Hara T; Soeda K; Kishimoto O; Kaneyuki H; Mizuki Y; Yamada M
Yakubutsu Seishin Kodo; 1988 Dec; 8(4):463-70. PubMed ID: 2907957
[TBL] [Abstract][Full Text] [Related]
2. Multifocal sites of action involved in dopaminergic-cholinergic neuronal interactions in yawning.
Ushijima I; Mizuki Y; Yamada M
Psychopharmacology (Berl); 1988; 95(1):34-7. PubMed ID: 3133698
[TBL] [Abstract][Full Text] [Related]
3. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Zarrindast MR; Poursoltan M
Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
[TBL] [Abstract][Full Text] [Related]
4. [Age-related modification of dopaminergic-cholinergic neuronal interaction in rats].
Kishimoto O
Yakubutsu Seishin Kodo; 1988 Dec; 8(4):443-51. PubMed ID: 3250156
[TBL] [Abstract][Full Text] [Related]
5. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Ushijima I; Noda Y; Mizuki Y; Yamada M
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
[TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of dilazep on cholinergic, dopaminergic, and purinergic systems in the rat.
Ushijima I; Mizuki Y; Ukita T; Kaneyuki H; Inano S; Yamada M
Pharmacol Biochem Behav; 1992 Nov; 43(3):673-6. PubMed ID: 1360158
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of yawning behavior induced by apomorphine, physostigmine and pilocarpine.
Ushijima I; Mizuki Y; Imaizumi J; Yamada M; Noda Y; Yamada K; Furukawa T
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):196-201. PubMed ID: 4004417
[TBL] [Abstract][Full Text] [Related]
8. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
Ushijima I; Mizuki Y; Yamada M
Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
[TBL] [Abstract][Full Text] [Related]
9. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
Bourson A; Moser PC
Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
[TBL] [Abstract][Full Text] [Related]
10. Modifications on dopaminergic and cholinergic systems induced by the water tank technique: analysis through yawning behavior.
Neumann BG; Troncone LR; Braz S; Tufik S
Arch Int Pharmacodyn Ther; 1990; 308():32-8. PubMed ID: 2099135
[TBL] [Abstract][Full Text] [Related]
11. Yawning produced by dopamine agonists in rhesus monkeys.
Code RA; Tang AH
Eur J Pharmacol; 1991 Aug; 201(2-3):235-8. PubMed ID: 1686760
[TBL] [Abstract][Full Text] [Related]
12. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
Zarkovsky AM; Cereska KS
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
[TBL] [Abstract][Full Text] [Related]
13. Effects of age on behavioral responses to dopamine agonists in the rat.
Ushijima I; Mizuki Y; Soeda K; Kishimoto O; Hara T; Yamada M
Eur J Pharmacol; 1987 Jun; 138(1):101-6. PubMed ID: 2887433
[TBL] [Abstract][Full Text] [Related]
14. Apomorphine produced more yawning in Sprague-Dawley rats than in F344 rats: a pharmacological study.
Tang AH; Himes CS
Eur J Pharmacol; 1995 Sep; 284(1-2):13-8. PubMed ID: 8549616
[TBL] [Abstract][Full Text] [Related]
15. Yawning induced by apomorphine, physostigmine or pilocarpine is inhibited by electroconvulsive shock (ECS).
Wielosz M; Szymczyk H
Acta Physiol Hung; 1996; 84(4):473-5. PubMed ID: 9328636
[TBL] [Abstract][Full Text] [Related]
16. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
Minematsu N
Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic and nicotinic effects on yawning and tongue protruding in the rat.
Ushijima I; Yamada K; Inoue T; Tokunaga T; Furukawa T; Noda Y
Pharmacol Biochem Behav; 1984 Aug; 21(2):297-300. PubMed ID: 6541344
[TBL] [Abstract][Full Text] [Related]
18. Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning.
Yamada K; Furukawa T
Psychopharmacology (Berl); 1980 Jan; 67(1):39-43. PubMed ID: 6768077
[TBL] [Abstract][Full Text] [Related]
19. Effects of cholinergic and GABAergic drugs on apomorphine-induced gnawing behavior in rats.
Rastogi SK; Rastogi RB; Singhal RL; Lapierre YD
Biol Psychiatry; 1982 Aug; 17(8):937-46. PubMed ID: 6288127
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of two cholinergically mediated central effects: stereotyped yawning and potentiation of head-shaking.
Holmgren B; Urbá-Holmgren R
Acta Neurobiol Exp (Wars); 1978; 38(1):11-23. PubMed ID: 566022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
